METHOD AND SYSTEM FOR METADATA MAINTENANCE IN A DATA LAKE

The present disclosure provides a method and a system for identifying stale data sets in the data lake for deprecation. The system comprises a metadata Hub, having a processor and a memory, and may act as a central repository. The metadata hub may also include a deprecator system or a deprecator, that uses an AI (artificial intelligence) model to deprecate unused datasets. The metadata hub may be communicatively connected to a large-scale data repository, also known as a data lake. The metadata hub may be configured to control the flow of ingest data from any relational database into the data lake. The data lake may include any data storage technology for offering storage for all data types. The metadata hub may be configured to send meta pulse queries to the data lake, where the meta pulse queries are used to pull usage stats of datasets, which includes identifying one or more actions performed on the datasets stored in the data lake. In response to the meta pulse queries the data lake is configured to provide a response pulse or metadata pulses indicating, the one or more actions performed on the datasets stored in the data lake. Upon receiving the response pulses, the metadata hub may be configured to perform one or more response actions on the datasets stored in the data lake, based on the response pulses. The one or more response actions may include deprecation of unused datasets by the deprecator system in the metadata hub, using a decision tree model algorithm

Drug utilization evaluation of antibiotics in district hospital Rudraprayag

Drug utilization is very important for antibiotics as they are widely used in hospitals and their in appropriate use may lead to resistance. To check this irrational use of antibiotics and promote rational use the present retrospective study was conducted to access drug utilization evaluation of antibiotics in in patient department of District Hospital Rudraprayag for a period of three months. Overall 126 patients records were encountered in the study in which male female ratio .was 1 2. Prominent age range was 21-40. Overall 1064 drugs were prescribed average number of drug per prescription was 8.44. Percentage of drug by generic name was 33. Percentage of antibiotic prescribed was 82.74. Percentage of drugs with EDL was 66.16. Study results revealed poly-pharmacy, brand prescribing as common trends. Study showed need to promote prescribers to follow generic prescribing and use injectable and antibiotics rationally to prevent development of resistance in hospital and community. Keywords: Antibiotic resistance, Drug utilization, Antibiotic

Bioactive characterization of Persea americana Mill. by-products: A rich source of inherent antioxidants

[EN] Avocado (Persea americana Mill.) is a worldwide consumed fruit, with great interest for cosmetic and pharmaceutical industries; however, 30% of avocado fruits are bio-wastes (peels and kernels), converting them into a potential source of bioactive compounds, such as phenolic compounds. Therefore, the hydroethanolic extracts of peels and kernels of Persea america Mill. var. Hass were analysed regarding their individual phenolic profile by HPLC-DAD/ESI-MS and correlated with their antioxidant, antimicrobial and cytotoxic activities. Avocado by-products presented a very distinct phenolic profile, presenting higher concentration in peels (227.9 mg/g of extract for total phenolic content), mainly in (epi)catechin derivatives (175 mg/g of extract), followed by chlorogenic derivatives (42.9 mg/g of extract). In this study hydrophilic and lipophilic antioxidant assays were performed together for the first time in P. americana by-products, and although kernels showed a great antioxidant potential (EC50 values ranging from 18.1 to 276 mu g/mL), peels presented the highest potential (EC50 ranging from 11.7 to 152 mu g/mL), mainly due to the presence of phenolic compounds, and an overall better performance in the antibacterial assays. Further studies needs to be conducted to better understand the correlation between the presence of phenolic compounds and bioactivities, however, the main objective is to implement these biocompounds in different products and industries, due to results obtained, P. americana peels could be a great alternative in the substitution of synthetic antioxidants.The authors are grateful to the Foundation for Science and Technology(FCT, Portugal) and FEDER under Program PT2020 for financial support to CIMO (UID/AGR/00690/2013) and L. Barros contract. The authors would like to thank the Interreg Espana-Portugal for financial support through the project 0377_Iberphenol_6_E. B. Melgar thanks CONACyT for his grant (No. 329930). The authors are also grateful to the Serbian Ministry of Education, Science and Technological Development, grant number 173032 for financial support.Melgar-Castañeda, B.; Dias, MI.; Ciric, A.; Sokovic, M.; Garcia-Castello, EM.; Rodríguez López, AD.; Barros, L.... (2018). Bioactive characterization of Persea americana Mill. by-products: A rich source of inherent antioxidants. Industrial Crops and Products. 111:212-218. https://doi.org/10.1016/j.indcrop.2017.10.024S21221811

Future cities and autonomous vehicles: analysis of the barriers to full adoption

The inevitable upcoming technology of autonomous vehicles (AVs) will affect our cities and several aspects of our lives. The widespread adoption of AVs repose at crossing distinct barriers that prevent their full adoption. This paper presents a critical review of recent debates about AVs and analyse the key barriers to their full adoption. This study has employed a mixed research methodology on a selected database of recently published research works. Thus, the outcomes of this review integrate the barriers into two main categories; (1) User/Government perspectives that include (i) Users' acceptance and behaviour, (ii) Safety, and (iii) Legislation. (2) Information and Communication Technologies (ICT) which include (i) Computer software and hardware, (ii) Communication systems V2X, and (iii) accurate positioning and mapping. Furthermore, a framework of barriers and their relations to AVs system architecture has been suggested to support future research and technology development

Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease

Background: Experimental and clinical data suggest that reducing inflammation without affecting lipid levels may reduce the risk of cardiovascular disease. Yet, the inflammatory hypothesis of atherothrombosis has remained unproved. Methods: We conducted a randomized, double-blind trial of canakinumab, a therapeutic monoclonal antibody targeting interleukin-1β, involving 10,061 patients with previous myocardial infarction and a high-sensitivity C-reactive protein level of 2 mg or more per liter. The trial compared three doses of canakinumab (50 mg, 150 mg, and 300 mg, administered subcutaneously every 3 months) with placebo. The primary efficacy end point was nonfatal myocardial infarction, nonfatal stroke, or cardiovascular death. RESULTS: At 48 months, the median reduction from baseline in the high-sensitivity C-reactive protein level was 26 percentage points greater in the group that received the 50-mg dose of canakinumab, 37 percentage points greater in the 150-mg group, and 41 percentage points greater in the 300-mg group than in the placebo group. Canakinumab did not reduce lipid levels from baseline. At a median follow-up of 3.7 years, the incidence rate for the primary end point was 4.50 events per 100 person-years in the placebo group, 4.11 events per 100 person-years in the 50-mg group, 3.86 events per 100 person-years in the 150-mg group, and 3.90 events per 100 person-years in the 300-mg group. The hazard ratios as compared with placebo were as follows: in the 50-mg group, 0.93 (95% confidence interval [CI], 0.80 to 1.07; P = 0.30); in the 150-mg group, 0.85 (95% CI, 0.74 to 0.98; P = 0.021); and in the 300-mg group, 0.86 (95% CI, 0.75 to 0.99; P = 0.031). The 150-mg dose, but not the other doses, met the prespecified multiplicity-adjusted threshold for statistical significance for the primary end point and the secondary end point that additionally included hospitalization for unstable angina that led to urgent revascularization (hazard ratio vs. placebo, 0.83; 95% CI, 0.73 to 0.95; P = 0.005). Canakinumab was associated with a higher incidence of fatal infection than was placebo. There was no significant difference in all-cause mortality (hazard ratio for all canakinumab doses vs. placebo, 0.94; 95% CI, 0.83 to 1.06; P = 0.31). Conclusions: Antiinflammatory therapy targeting the interleukin-1β innate immunity pathway with canakinumab at a dose of 150 mg every 3 months led to a significantly lower rate of recurrent cardiovascular events than placebo, independent of lipid-level lowering. (Funded by Novartis; CANTOS ClinicalTrials.gov number, NCT01327846.

Impact of opioid-free analgesia on pain severity and patient satisfaction after discharge from surgery: multispecialty, prospective cohort study in 25 countries

Background: Balancing opioid stewardship and the need for adequate analgesia following discharge after surgery is challenging. This study aimed to compare the outcomes for patients discharged with opioid versus opioid-free analgesia after common surgical procedures.Methods: This international, multicentre, prospective cohort study collected data from patients undergoing common acute and elective general surgical, urological, gynaecological, and orthopaedic procedures. The primary outcomes were patient-reported time in severe pain measured on a numerical analogue scale from 0 to 100% and patient-reported satisfaction with pain relief during the first week following discharge. Data were collected by in-hospital chart review and patient telephone interview 1 week after discharge.Results: The study recruited 4273 patients from 144 centres in 25 countries; 1311 patients (30.7%) were prescribed opioid analgesia at discharge. Patients reported being in severe pain for 10 (i.q.r. 1-30)% of the first week after discharge and rated satisfaction with analgesia as 90 (i.q.r. 80-100) of 100. After adjustment for confounders, opioid analgesia on discharge was independently associated with increased pain severity (risk ratio 1.52, 95% c.i. 1.31 to 1.76; P < 0.001) and re-presentation to healthcare providers owing to side-effects of medication (OR 2.38, 95% c.i. 1.36 to 4.17; P = 0.004), but not with satisfaction with analgesia (beta coefficient 0.92, 95% c.i. -1.52 to 3.36; P = 0.468) compared with opioid-free analgesia. Although opioid prescribing varied greatly between high-income and low- and middle-income countries, patient-reported outcomes did not.Conclusion: Opioid analgesia prescription on surgical discharge is associated with a higher risk of re-presentation owing to side-effects of medication and increased patient-reported pain, but not with changes in patient-reported satisfaction. Opioid-free discharge analgesia should be adopted routinely

Erratum: Global, regional, and national comparative risk assessment of 84 behavioural, environmental and occupational, and metabolic risks or clusters of risks for 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017

Interpretation: By quantifying levels and trends in exposures to risk factors and the resulting disease burden, this assessment offers insight into where past policy and programme efforts might have been successful and highlights current priorities for public health action. Decreases in behavioural, environmental, and occupational risks have largely offset the effects of population growth and ageing, in relation to trends in absolute burden. Conversely, the combination of increasing metabolic risks and population ageing will probably continue to drive the increasing trends in non-communicable diseases at the global level, which presents both a public health challenge and opportunity. We see considerable spatiotemporal heterogeneity in levels of risk exposure and risk-attributable burden. Although levels of development underlie some of this heterogeneity, O/E ratios show risks for which countries are overperforming or underperforming relative to their level of development. As such, these ratios provide a benchmarking tool to help to focus local decision making. Our findings reinforce the importance of both risk exposure monitoring and epidemiological research to assess causal connections between risks and health outcomes, and they highlight the usefulness of the GBD study in synthesising data to draw comprehensive and robust conclusions that help to inform good policy and strategic health planning

Cellular cannibalism: A promising feature to determine cancer prognosis

Cellular cannibalism is defined as the ability of a cell to engulf another living cell leading eventually to the death of the internalized cell. It has been considered as an important morphologic feature to distinguish benign from malignant lesions and an emerging indicator of both the anaplastic grade and invasiveness. Cannibalism has even been hypothesized to be related to the metastatic capabilities of malignant cells. It is considered as a sort of “feeding” activity aimed at sustaining survival and progression of malignant tumor cells in an unfavorable microenvironment. Cell-in-cell formation promotes tumor progression, by inducing changes in cell ploidy. It is especially valuable as it eventually helps in assessing tumor behavior. It may function as a way of eliminating malignant cells or alternatively the ingested cell may serve as a source of nutrients for the proliferating cell that shows this cannibalistic behavior

Structural and opto-electronic features of pulsed laser ablation grown Cu2ZnSnS4 films for photovoltaic applications

We report synthesis of Cu2ZnSnS4 thin films of kesterite structure by sulfurization of pulsed laser deposited (PLD) CuZnSn composite films at optimized temperature. These films show sharp optical absorption edge in the range of 1.4-1.6 eV, when prepared under optimized conditions of deposition and sulfurization. In general, the processed films are found to be non-stoichiometric with deficiency of S and excess of Zn. Electrical conductivity measurements in the temperature range 50-300 K reveal hopping transport with activation energies <= 20 meV at T < 80 K and a room temperature resistivity varying from 0.1 to 2.7 Omega-cm

Current Update on Biomarkers for Detection of Cancer: Comprehensive Analysis

Early and effective diagnosis of cancer is decisive for its proper management. In this context biomarker-based cancer diagnosis is budding as one of the promising ways for early detection, disease progression monitoring, and effective cancer therapy. Integration of Biosensing devices with different metallic/nonmetallic nanoparticles offers amplification and multiplexing capabilities for simultaneous detection of cancer biomarkers (CB&rsquo;s). This study provides a comprehensive analysis of the most recent designs and fabrication methodologies designed for developing electrochemical biosensors (EB) for early detection of cancers. The role of biomarkers in cancer therapeutics is also discussed